Provided by Tiger Trade Technology Pte. Ltd.

Psyence Biomedical Ltd

3.13
+0.24008.30%
Post-market: 3.08-0.0500-1.60%19:47 EST
Volume:104.38K
Turnover:315.17K
Market Cap:3.20M
PE:-1.49
High:3.27
Open:2.85
Low:2.75
Close:2.89
52wk High:74.94
52wk Low:2.54
Shares:1.02M
Float Shares:970.74K
Volume Ratio:0.09
T/O Rate:10.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1050
EPS(LYR):32.76
ROE:-74.29%
ROA:-34.44%
PB:0.27
PE(LYR):0.10

Loading ...

Cigna's Reassurances About PBM Business Lift Stock -- WSJ

Dow Jones
·
Yesterday

CVS Health Faces New PBM Transparency Test With Earnings Engine In Focus

Simply Wall St.
·
Feb 05

Top Premarket Decliners

MT Newswires Live
·
Feb 03

NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:31 AM

Reuters
·
Feb 02

NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM

Reuters
·
Feb 01

Psyence Biomedical Ltd trading halted, news pending

TIPRANKS
·
Jan 31

Psyence Biomedical Announces 1-for-6.25 Reverse Stock Split Effective February 2

Reuters
·
Jan 29

Psyence Biomed Announces Effective Date for 1-for-6.25 Reverse Stock Split

THOMSON REUTERS
·
Jan 29

Press Release: MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH

Dow Jones
·
Jan 27

Press Release: Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026

Dow Jones
·
Jan 23

NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:35 AM

Reuters
·
Jan 20

Psyence BioMed Postpones Planned Reverse Stock Split

Reuters
·
Jan 20

Psyence Biomed Announces Postponement of Previously Announced Reverse Stock Split Effective Date

THOMSON REUTERS
·
Jan 20

Psyence Biomedical Ltd trading halted, news pending

TIPRANKS
·
Jan 17

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Reuters
·
Jan 17

Psyence Biomed Announces Effective Date for 1-for-6.25 Reverse Stock Split

THOMSON REUTERS
·
Jan 15

Psyence BioMed Enacts 1-for-6.25 Reverse Stock Split

Reuters
·
Jan 15

BRIEF-Psyence Biomed Approves 2026 Financial Strategy, Board Authorizes Share Buyback On Value Opportunity

Reuters
·
Jan 12

Psyence Biomedical Ltd. publishes MD&A report for year ended March 31, 2025

Reuters
·
Jan 09

Psyence BioMed Appoints Graham Patrick to Board as Christopher Bull Resigns

Reuters
·
Jan 05